Plum Health

AUGUST 30, 2024

Managing diabetes—especially as you get older—can be challenging physically, emotionally, and financially. If you’re living with Type 2 diabetes, you’ve probably heard of Ozempic, Wegovy (semaglutide), Mounjaro or Zepbound (tirzepatide). Save with a copay savings card. Save with patient assistance programs.

Primary Care 52

Primary Care Insurance Diabetes Manufacturing 52

Imperial Center Family Medicine

MAY 26, 2025

When managing your cholesterol through diet, the types of fats and oils you cook with can make a significant difference. In one study , using sesame oil regularly for 90 days significantly improved blood sugar and cholesterol levels in people with diabetes. Look for unrefined sesame oil to get the most cholesterol-lowering benefits.

Management 52

Management Screening DO Family Medicine 52

FDA Law Blog

JULY 22, 2021

Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Both states’ new requirements will become effective in October 2021 and should be considered as manufacturers prepare for state drug price transparency reporting in 2022.

Manufacturing 52

Manufacturing Asthma Diabetes Families 52

GeriPal

JUNE 20, 2024

But that combination is actually quite common, and it’s quite challenging to diagnose and manage, at least in the traditional sense. We think of it really as a kind of a management tool as well. In terms of how you can, how you can manage these issues. George 19:37 Exactly, exactly. And that can be incredibly powerful.

IT 120

IT Patient-Centered Patients Clinic 120

FDA Law Blog

SEPTEMBER 8, 2022

As it stands, the rule allows insurers and pharmacy benefit managers (PBMs) to broadly use copay accumulator programs, which have long been criticized by patient advocacy groups as padding insurers’ pockets while leaving patients high and dry. These prohibitions are often referred to as copay accumulator adjustment programs.

Insurance 83

Insurance Patients Manufacturing Patient-Centered 83

FDA Law Blog

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98